- Report
- January 2026
- 187 Pages
Global
From €3128EUR$3,545USD£2,707GBP
€3475EUR$3,939USD£3,007GBP
- Report
- May 2026
- 152 Pages
Global
From €5161EUR$5,850USD£4,466GBP
- Report
- February 2026
- 250 Pages
Global
From €3961EUR$4,490USD£3,428GBP
- Report
- February 2026
- 250 Pages
Global
From €3961EUR$4,490USD£3,428GBP
- Report
- September 2025
- 150 Pages
Global
From €4279EUR$4,850USD£3,703GBP
- Report
- August 2025
- 195 Pages
Global
From €3128EUR$3,545USD£2,707GBP
€3475EUR$3,939USD£3,007GBP
- Report
- January 2026
- 185 Pages
Global
From €3970EUR$4,500USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €3961EUR$4,490USD£3,428GBP
- Report
- February 2026
- 195 Pages
Global
From €4279EUR$4,850USD£3,703GBP
- Report
- May 2025
- 560 Pages
Global
From €4367EUR$4,950USD£3,779GBP
- Report
- August 2025
- 150 Pages
Global
From €5250EUR$5,950USD£4,543GBP
- Report
- September 2025
- 100 Pages
Global
From €4323EUR$4,900USD£3,741GBP
- Report
- January 2026
- 326 Pages
Global
From €3970EUR$4,500USD£3,436GBP
- Report
- September 2025
- 150 Pages
Global
From €3528EUR$3,999USD£3,053GBP
- Report
- October 2025
- 150 Pages
Global
From €5250EUR$5,950USD£4,543GBP
- Report
- October 2025
- 150 Pages
Global
From €5250EUR$5,950USD£4,543GBP
- Report
- June 2025
- 150 Pages
Global
From €5250EUR$5,950USD£4,543GBP
- Report
- January 2026
- 182 Pages
Global
From €3128EUR$3,545USD£2,707GBP
€3475EUR$3,939USD£3,007GBP
- Report
- January 2026
- 186 Pages
Global
From €3128EUR$3,545USD£2,707GBP
€3475EUR$3,939USD£3,007GBP
- Report
- May 2026
- 278 Pages
Global
From €5161EUR$5,850USD£4,466GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more